tiprankstipranks
Trending News
More News >
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Cash flow

Compare
287 Followers

Lexeo Therapeutics, Inc. Cash Flow

LXEO's free cash flow for Q3 2025 was $-29.84M. For the 2025 fiscal year, LXEO's free cash flow was decreased by $-21.97M and operating cash flow was $-29.55M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -81.15M$ -59.50M$ -54.56M$ -44.18M$ -3.13M
Investing Cash Flow
$ -94.08M$ -165.00K$ -901.00K$ -188.00K$ 0.00
Financing Cash Flow
$ 88.78M$ 103.79M$ 189.00K$ 150.86M$ 32.38M
End Cash Position
$ 38.27M$ 124.72M$ 80.59M$ 135.86M$ 29.37M
Free Cash Flow
$ -81.63M$ -59.66M$ -55.46M$ -44.37M$ -3.13M
Currency in USD

Lexeo Therapeutics, Inc. Cash Flow